Loading…
BIOA
BioAge Labs, Inc.
NASDAQ· Healthcare· Drug Manufacturers - Specialty & Generic· CUSIP 09077V100
$4.84-9.53%Price as of Oct 17, 12:04 UTC · updated once a day, after the close
At a glance
BioAge Labs, Inc. (BIOA) is listed on NASDAQ and classified in Drug Manufacturers - Specialty & Generic, part of the Healthcare sector. It is headquartered in EmeryVille, United States and has 60 employees. The company is worth $222.14M. Revenue was $9M in fiscal 2025. It reported a net loss of $80.61M. The share price is 81.4% below its 52-week high of $25.96. 5 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Israel Englander (Millennium Management), at $5.46M. In that quarter, 1 of them opened or added to the position and 1 reduced it. No open-market insider trades in it were filed over the last 30 days.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Key metrics
- Market cap
- $222.14M
- P/E
- —
- Forward P/E
- —
- P/B
- 0.6x
- Dividend yield
- 0.00%
- Payout
- —
- EPS
- -$2.39
- ROE
- -28.21%
- Profit margin
- 0.00%
- Revenue growth
- +1.60%
- Beta
- 1.08
- 52-week high
- $25.96
- 52-week low
- $4.81
History
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -76.7% over 5Y.
This stock has less than 5 years of price history — the answer would measure a shorter period than the one asked for.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 2 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 |
|---|---|---|---|
| Year-end price | $13.23 | $5.79 | |
| P/S | — | 65.3x | — |
| P/B | — | 2.2x | 0.6x |
| EPS | -$2.24 | -$6.63 | |
| Profit margin | — | -896.11% | — |
| ROE | — | -29.63% | -22.01% |
Median of the years shown; P/E years above 200x are left out.
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| TLSITriSalus Life Sciences, Inc. | $3.63 | — | 33.9x | 0.00% | — | $223.52M |
| QTTBQ32 Bio Inc. | $7.52 | 2.4x | 1.7x | 0.00% | 72.14% | $223.87M |
| SPOKSpok Holdings, Inc | $10.71 | 18.2x | 1.6x | 11.67% | 8.42% | $224.03M |
| PROFProfound Medical Corp. | $6.01 |
About the company
- 60
- EmeryVille, United States